Genomics Personalized Health
What combination of drivers is leading to accelerated growth in the genomics personalized health market?
The growing demand for personalized medicine is expected to boost the genomics personalized health market. Personalized medicine customizes treatment based on an individual’s genetic makeup. The demand for personalized medicine is increasing due to better disease understanding and the rising prevalence of chronic conditions. Genomics personalized health uses genetic information to tailor medical care from prevention to treatment. The Personalized Medicine Coalition reported that in 2023, the FDA approved 16 personalized therapies, up from six in 2022. This growing demand for personalized medicine is driving the genomics personalized health market.
Get Your Genomics Personalized Health Market Report Here:
https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report
What is the projected compound annual growth rate (CAGR) of the genomics personalized health market from 2025 to 2034, and what factors influence it?
The genomics personalized health market has seen strong growth. It is expected to grow from $15.97 billion in 2024 to $18.58 billion in 2025, with a CAGR of 16.4%. This growth is driven by advancements in genomics research, government funding, an increase in chronic diseases, technological innovations, investment from the pharmaceutical industry, and new collaborations and partnerships.
The genomics personalized health market is expected to grow to $33.6 billion by 2029, at a CAGR of 16.0%. Growth drivers include healthcare investments, genomics technology adoption, personalized medicine applications, rising genetic disorders, and chronic diseases. Major trends include wearable technology integration, direct-to-consumer genetic testing, CRISPR advancements, digital health integration, and precision medicine growth.
Get Your Free Sample Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15814&type=smp
How are the latest trends influencing the growth of the genomics personalized health market?
Companies in the genomics personalized health market are prioritizing the development of products like cloud-based software for tertiary analysis of clinical next-generation sequencing (NGS) data to stay competitive. NGS data involves genetic information obtained from sequencing technologies that enable detailed DNA or RNA analysis in clinical settings. For example, in March 2023, Illumina, a US-based biotech company, launched Connected Insights, a cloud platform designed to facilitate tertiary analysis of clinical NGS data, particularly in oncology. This software integrates multiple third-party knowledge bases to enhance data analysis and improve precision care initiatives.
What are the major segments of the genomics personalized health market and their role in driving growth?
The genomics personalized health market covered in this report is segmented –
1) By Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Other Test Type
2) By Technology: NGS platforms, RT-PCR, Microarray, Genetic Analyzers
3) By End User: Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) Oncology Testing: Cancer Genomic Profiling, Liquid Biopsy Testing, Tumor Mutational Burden Testing, Genetic Biomarker Testing
2) Infectious Disease Testing: PCR-Based Tests, Next-Generation Sequencing (NGS) Tests, Microbial Genomic Profiling
3) Orphan Disease Testing: Genetic Screening For Rare Diseases, Genetic Testing For Inherited Disorders, Targeted Gene Panels
4) Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions, Immune System Gene Profiling, HLA Typing Tests
5) Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT), Genetic Screening For Birth Defects, Carrier Screening Tests
6) Other Test Type: Cardiovascular Genetic Testing, Neurological Disease Testing, Metabolic Disease Genetic Testing
Unlock Exclusive Market Insights – Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15814
Which region dominates the genomics personalized health market?
North America was the largest region in the personalized health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the key firms paving the way for growth in the genomics personalized health market?
Major companies operating in the genomics personalized health market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Quest Diagnostics, Agilent Technologies Inc., Lonza Group, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Personalis Inc., DNA Genotek Inc., Twist Bioscience Corporation, GRAIL Inc., Eastern Biotech and Life Sciences, INVITAE Corporation, Genetic Technologies Limited, XCode Life Sciences Private Limited, Biome Inc., BGI Genomics Co. Ltd.
Customize Your Report – Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15814&type=smp
What Is Covered In The Genomics Personalized Health Global Market Report?
•Market Size Forecast: Examine the genomics personalized health market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the genomics personalized health market for a structured understanding.
•Key Players Overview: Analyze major players in the genomics personalized health market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the genomics personalized health market.
•Segment Contributions: Evaluate how different segments drive overall growth in the genomics personalized health market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the genomics personalized health market.
•Industry Challenges: Identify potential risks and obstacles affecting the genomics personalized health market.
•Competitive Landscape: Review strategic developments in the genomics personalized health market, including expansions, agreements, and new product launches.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
